A Rare Dermatologic Disease in Pregnancy: Rosacea Fulminans- Case Report and Review of the Literature

  • Omer Demir Clinic of Obstetrics and Gynecology, Erzurum Karayazı Turkish Pharmacists Union, County State Hospital, Erzurum
  • Inci Sema Tas Clinic of Obstetrics and Gynecology, Istanbul School of Medicine, Istanbul University, Istanbul
  • Berrin Gunay Clinic of Dermatology, Cizre Dr Selahattin Cizrelioglu County State Hospital, Sırnak
  • Funda Gungor Ugurlucan Clinic of Obstetrics and Gynecology, Istanbul School of Medicine, Istanbul University, Istanbul
Keywords: Rosacea, Pregnancy, Rare disease


BACKGROUND: Rosacea is a common, chronic disorder that can present with a variety of cutaneous or ocular manifestations. Skin involvement primarily affects the central face, with findings such as persistent centrofacial redness, papules, pustules, flushing, telangiectasia, and phymatous skin changes. The pathways that lead to the development of rosacea are not well understood. The relationship of pyoderma faciale (also known as rosacea fulminans) to rosacea also is uncertain. We aimed to write this article with the aim of showing how a pregnant patient who has been aggravated by the degree of lesions on the face during the first trimester of pregnancy is treated and to show what is in the literature in this issue.

CASE REPORT: A 22-year-old woman complained of painful erythema, papules and pustules on the face. She had fever and malaise during the sixth week of her first pregnancy and a history of the mild eruption and seborrhea before her pregnancy with flaring over the preceding 4 weeks. Dermatologic examination revealed red erythema of all involved facial areas; the lesions consisted of papules, pustules and nodules. The case was diagnosed as rosacea fulminans (pyoderma faciale) by these findings. In the literature, there are some effective therapeutic options such as retinoids, tetracyclines, antiandrogenic contraceptives, and dapsone and these were not used because they are contraindicated in pregnancy. Amoxicillin-clavulanic acid 1 gr/day, wet compresses, and a fusidic acid cream were started. After the activity of the disease had been suppressed for 10 days, antibiotic was stopped, and the other treatment options were applied topically for the next month. One month after cessation of treatment, the lesions had disappeared with only mild erythema remaining. There was minimally flushing on the face and no telangiectasia.

CONCLUSION: In conclusion, there is no substantial evidence as to the mechanism by which pregnancy may trigger this conditioner whether the gender of the fetus influences the development of rosacea fulminans, but is generally accepted that hormonal changes in pregnancy play an important role. The pathogenesis of rosacea fulminans remains uncertain, but it is obvious that the further basic and clinical research is required to optimise the management of this rare facial dermatosis.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Mc Aleer MA,Lacey N,Powell FC. The pathophysiology of rosacea. G Ital Dermatol Venereol. 2009; 144:663. PMid:19907405

Dahl MV. Pathogenesis of rosacea. Adv Dermatol. 2001; 17-29.

Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002; 46-584. https://doi.org/10.1067/mjd.2002.120625

Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea:The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018; 78-148.

Tan J, Almeida LM, Bewley A,et al. Updating the diagnosis,classification and assessment of rosacea:recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017; 176:431. https://doi.org/10.1111/bjd.15122 PMid:27718519

Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol. 1969; 100:683. https://doi.org/10.1001/archderm.1969.01610300033005 PMid:4243753

Plewig G, Jansen T. Rosacea. Disorders of epidermal appendages and related disorders. In: Fitzpatrick TB, Freedberg IM, Eisen AZ, et al.,editors. Dermatology in general medicine.5th ed. New York (NY): McGraw-Hill,1999;785-92.

Plewig G, Jansen T, Kligman AM. Pyoderma faciale:a review and report of 20 additional cases:is it rosacea? Arch Dermatol. 1992; 128:1611-7. https://doi.org/10.1001/archderm.1992.04530010049007 PMid:1456755

Goh CL. Clinician's photo guide to recognizing and treating skin diseases in women. Part 1: dermatoses not linked to pregnancy. Medscape Women's Health. 1997; 2:3. PMid:9746712

Massa MC, Su WP. Pyoderma faciale:a clinical study of twenty-nine patient's. J Am Acad Dermatol. 1982; 6:84-91. https://doi.org/10.1016/S0190-9622(82)70008-8

Haugstvedt A, Bjerke JR. Rosacea fulminans with extrafacial lesions. Acta Derm Venerol. 1998; 78:70-1. https://doi.org/10.1080/00015559850135922 PMid:9498036

Lewis VJ, Holme SA, Wright A, et al. Rosacea fulminans in pregnancy. Br J Dermatol. 2004; 151(4):917-9. https://doi.org/10.1111/j.1365-2133.2004.06190.x PMid:15491439

Ferahbas A, Utas S, Mistik S,Uksal U, Peker D. Rosacea fulminans in pregnancy:case report and review of the literatüre. Am J Clin Dermatol. 2006; 7(2):141-4. https://doi.org/10.2165/00128071-200607020-00007 PMid:16605294

Cisse M, Maruani A, Bre C, Domart P, Jonville-Bera AP, Machet L. Rosacea fulminans in the early course of a pregnancy by in vitro fertilization with embryo transfer. Ann Dermatol Venereol. 2008; 135(10):675-8. https://doi.org/10.1016/j.annder.2008.04.015 PMid:18929918

Jarrett R, Gonsalves R, Anstey AV. Differing obstetric outcomes of rosacea fulminans in pregnancy:report of three cases with review of pathogenesis and management. Clin Exp Dermatol. 2010; 35(8):888-91. https://doi.org/10.1111/j.1365-2230.2010.03846.x PMid:20456381

de Morais e Silva FA,Bonassi M,Steiner D,da Cunha TV. Rosacea fulminans in pregnancy with ocular perforation. J Dtsch Dermatol Ges. 2011; 9(7):542-3. https://doi.org/10.1111/j.1610-0387.2011.07616.x PMid:21366860

Fuentelsaz V, Ara M, Corredera C, Lezcano V, Juberias P, Carapeto FJ. Rosacea fulminans in pregnancy:successful treatment with azithromycin. Clin Exp Dermatol. 2011; 36(6):674-6. https://doi.org/10.1111/j.1365-2230.2011.04042.x PMid:21714808

Wollina U. Recent advances in the understanding and management of rosacea. F1000Prime Rep. 2014; 6:50. https://doi.org/10.12703/P6-50 PMid:25184040 PMCid:PMC4108952

Haenen CC, Kouwenhoven ST, van Doorn R. Rosacea fulminans in pregnancy. Ned Tijdschr Geneeskd. 2015; 159:A8334. PMid:26058762

How to Cite
Demir O, Tas IS, Gunay B, Gungor Ugurlucan F. A Rare Dermatologic Disease in Pregnancy: Rosacea Fulminans- Case Report and Review of the Literature. Open Access Maced J Med Sci [Internet]. 2018Aug.4 [cited 2020Nov.27];6(8):1438-41. Available from: https://www.id-press.eu/mjms/article/view/oamjms.2018.267
C- Case Reports